RDHL
NASDAQ
IL
Redhill Biopharma Ltd. - American Depositary Shares
$0.80
▼ $-0.01
(-1.72%)
Vol 13K
6
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$4.7M
ROE
1955.7%
Margin
-102.3%
D/E
914.75
Beta
5.01
52W
$1–$7
Wall Street Consensus
7 analysts · Mar 20252
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 0.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Jun 2022 | $-30.60 | $-200.00 | $-169.40 |
| Mar 2022 | $-234.60 | $-300.00 | $-65.40 |
| Dec 2021 | $-336.60 | $-500.00 | $-163.40 |
| Sep 2021 | $-210.80 | $-500.00 | $-289.20 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | 1955.7% | 1955.7% | 1955.7% | 1955.7% | 1955.7% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -101.3% | -107.0% | -107.0% | -107.0% | -102.3% | -102.3% |
| Gross Margin | 60.6% | 56.7% | 56.7% | 56.7% | 60.4% | 60.4% |
| D/E Ratio | — | 914.75 | 914.75 | 914.75 | 914.75 | 914.75 |
| Current Ratio | 0.56 | 0.54 | 0.54 | 0.54 | 0.56 | 0.56 |
Key Ratios
ROA (TTM)
-68.1%
P/S (TTM)
0.39
P/B
13.9
EPS (TTM)
$0.00
CF/Share
$31.18
Rev Growth 3Y
-54.6%
52W High
$7.00
52W Low
$1.01
$1.01
52-Week Range
$7.00
How does RDHL compare to Pharmaceuticals peers?
Peer group: Micro-cap Pharmaceuticals (All) · 171 companies
RDHL valuation vs Pharmaceuticals peers
P/E ratio
—
▼
0%
below
peers
(22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
0.4
▼
92%
below
peers
(5.0)
vs Peers
vs Industry
Undervalued
P/B ratio
13.9
▲
555%
above
peers
(2.1)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(2.0%)
vs Peers
vs Industry
Low yield
RDHL profitability vs Pharmaceuticals peers
ROE
1955.7%
▲
3704%
above
peers
(-54.3%)
vs Peers
vs Industry
Top tier
Net margin
-102.3%
▼
116%
below
peers
(-47.4%)
vs Peers
vs Industry
Weak
Gross margin
60.4%
▼
12%
below
peers
(68.3%)
vs Peers
vs Industry
Weak
ROA
-68.1%
▼
82%
below
peers
(-37.4%)
vs Peers
vs Industry
Weak
RDHL financial health vs Pharmaceuticals peers
D/E ratio
914.8
▲
59299%
above
peers
(1.5)
vs Peers
vs Industry
High debt
Current ratio
0.6
▼
83%
below
peers
(3.4)
vs Peers
vs Industry
Low liquidity
Beta
5.0
▲
433%
above
peers
(0.9)
vs Peers
vs Industry
More volatile
RDHL fundamentals radar
RDHL
Peer median
Industry
RDHL profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
RDHL vs peers: key metrics
Latest News
No related news yet